InsiderPulseNo transactions found.
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| General and administrative | $149K-95.3% | $3.2M+321.3% | $763K |
| Professional fees | $22K-73.3% | $84K+27.2% | $66K |
| Total operating expenses | $172K-94.8% | $3.3M+297.8% | $829K |
| Loss from operations | -$172K+94.8% | -$3.3M-297.8% | -$829K |
| Gain on settlement of debt | $0-100.0% | $74K | $0 |
| Interest expense | -$36K+3.1% | -$37K-23.4% | -$30K |
| Total other expenses | -$36K-196.8% | $37K+104.1% | -$905K |
| Net loss before tax provision | -$207K+93.6% | -$3.3M-88.1% | -$1.7M |
| Tax provision | $0 | $0 | $0 |
| Net loss | -$207K+93.6% | -$3.3M-88.1% | -$1.7M |
| Net loss per common share - basic and diluted | -$0.01+90.9% | -$0.11 | — |
| Weighted average number of common shares outstanding - basic and diluted | $32.7M+11.5% | $29.3M | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
LataMed AI Corp. to Attend Meditech Colombia 2026 as Company Advances Latin American Commercialization Strategy
LataMed AI Corp. Announces Expected Effectiveness of Name and Symbol Change to LMED
Catalyst Crew Technologies Provides Update on Share Cancellation Initiative and Corporate Name Change
Catalyst Crew Technologies Announces Receipt of Venezuelan Health Authority Approval for Telehealth Platform Operations